Company profile
Akshaya Bio company profile
Akshaya develops innovative therapeutics for infectious diseases and cancer. Akshaya's proprietary Chimigen® Platform Technology uses dendritic cell receptor-targeted chimeric molecules to develop a portfolio of biotherapeutic agents to meet major unmet medical needs such as treatments for chronic hepatitis B and hepatitis C virus infections, avian and swine influenza, alphavirus infections, malaria, HIV and cancer.
Business identity
- Website
- http://akshayabio.com/
- Contact email
- [email protected]
- Phone number
- (780) 433-4411
- Operating status
- Active
- Company type
- For Profit
Headquarters
- Headquarters
- Edmonton, Alberta, Canada
- Country code
- CA
- Continent
- North America